Project Grant R01CA301371
Award Date 3/12/26
Completion Date 2/28/31
Dollars Obligated $635K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
- Federal Project Grant Award Summary The University of Wisconsin–Madison received a $630,171 Project Grant award from the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395), effective August 12, 2025 through July 31, 2030. This award supports the development of a first-in-class radiopharmaceutical therapy (RPT) targeting triple-negative breast cancer (TNBC), an aggressive cancer subtype with a five-year survival rate of 12% for metastatic cases. The research...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded UC San Diego a $988,224 Project Grant under the Cancer Treatment Research program (CFDA 93.395) to advance treatment strategies for head and neck cancer patients with competing health risks through multi-center randomized clinical trials. The four-year award, effective September 1, 2025 through August 31, 2029, supports the principal investigator's clinical research program focused on developing novel alternative therapeutic...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $427,625 Project Grant to The Washington University (awarded February 6, 2026, completion February 5, 2028) under the Oral Diseases and Disorders Research program (CFDA 93.121) to develop and evaluate radiation-guided theranostic agents for monitoring treatment response in head and neck squamous cell carcinoma (HNSCC). The research focuses on leveraging radiation-inducible tumor-associated...
- Federal Project Grant Award Summary The Medical College of Wisconsin, Inc. received a $632,314 Project Grant from the National Cancer Institute under the Cancer Treatment Research program (CFDA 93.395), awarded April 1, 2026, with a completion date of March 31, 2031. This award supports research and development of gallium maltolate (GAM), an iron-mimetic metallocompound, as a novel therapeutic treatment for difficult-to-treat pediatric central nervous system (CNS) tumors, specifically...
- Federal Project Grant Award Summary The National Cancer Institute awarded a Project Grant of $216,013 to the University of Wisconsin-Madison under the Cancer Biology Research program (CFDA 93.396), effective September 1, 2025 through August 31, 2027. This award supports fundamental research investigating the mechanisms by which caspases (cellular enzymes) and antiviral interferon (IFN) responses influence Kaposi's Sarcoma-Associated Herpesvirus (KSHV) tumorigenesis. The research addresses a...
- Federal Grant Award Summary The University of Wisconsin–Madison received a $603,981 Project Grant award from the National Cancer Institute under the Cancer Detection and Diagnosis Research program (CFDA 93.394), effective August 18, 2025, with completion targeted for July 31, 2030. This award supports the development and clinical validation of integrated artificial intelligence (AI) biomarkers combining genomic and digital pathology analysis to improve patient selection for high-risk prostate...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded a $730,398 Project Grant to Sloan-Kettering Institute for Cancer Research under the Cancer Treatment Research program (CFDA 93.395) effective April 1, 2026, through March 31, 2031. This research initiative focuses on understanding and overcoming treatment resistance in locally advanced rectal cancer (LARC) patients undergoing total neoadjuvant therapy (TNT)—a combined treatment regimen consisting of radiation therapy,...
- Federal Grant Award Summary The National Cancer Institute awarded a $736,168 Project Grant to Sloan-Kettering Institute for Cancer Research under the Cancer Treatment Research program (CFDA 93.395) for the period of August 1, 2025, through July 31, 2030. The research focuses on developing antigen-specific radiosensitization through antibody-drug conjugates (ADCs) and antibody-oligonucleotide conjugates (AOCs) designed to enhance the therapeutic index of radiotherapy. The project centers on two...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded a $662,682 Project Grant to the University of California, San Diego under the Cancer Treatment Research program (CFDA 93.395) on June 4, 2025, with an ultimate completion date of May 31, 2030. This award funds research investigating the prognostic and therapeutic roles of voltage-gated potassium channels in managing KIT mutant gastrointestinal stromal tumors (GISTs). The project will deliver a Phase 1 neoadjuvant...
- Federal Grant Award Summary The National Cancer Institute awarded a $2.58M Project Grant to the University of Wisconsin–Madison under the Cancer Detection and Diagnosis Research program (CFDA 93.394) on August 11, 2025, with completion targeted for July 31, 2030. This award supports research investigating molecular drivers and therapeutic susceptibilities in lineage state transitions of metastatic castrate-resistant prostate cancer (MCRPC). The research program addresses the critical clinical...